Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P4TG | ISIN: KYG5273B1077 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
KINTOR PHARMACEUTICAL LTD Chart 1 Jahr
5-Tage-Chart
KINTOR PHARMACEUTICAL LTD 5-Tage-Chart

Aktuelle News zur KINTOR PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.05.Kintor: Exclusive Global 20 Seats, China's Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone310SUZHOU, China, May 28, 2025 /PRNewswire/ -- In the newly announced entry list of the Inspiration Hive zone at the 2025 New York Society of Cosmetic Chemists (NYSCC) exhibition, Kintor's innovative...
► Artikel lesen
15.05.Kintor Pharma shifts from cancer drugs to cosmetics as funds run low1
13.05.KINTOR PHARMA-B (09939): (1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; ...1
13.05.KINTOR PHARMA-B (09939): NOTICE OF ANNUAL GENERAL MEETING-
KINTOR PHARMACEUTICAL Aktie jetzt für 0€ handeln
13.05.KINTOR PHARMA-B (09939): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING-
08.05.KINTOR PHARMA-B (09939): VOLUNTARY ANNOUNCEMENT - OFFICIAL COMMENCEMENT OF GLOBAL SALES BUSINESS OF WHITENING AND FRECKLE-REMOVING FUNCTIONAL COSMETIC ...1
02.05.KINTOR PHARMA-B (09939): VOLUNTARY ANNOUNCEMENT - SUPERIOR EFFICACY OF CLINICAL OBSERVATIONAL STUDY IN KX-826 IN COMBINATION WITH MINOXIDIL FOR THE TREATMENT ...1
29.04.KINTOR PHARMA-B (09939): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024-
29.04.KINTOR PHARMA-B (09939): ANNUAL REPORT 2024-
17.04.KINTOR PHARMA-B (09939): VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER DR. ...1
26.03.KINTOR PHARMA-B (09939): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024-
20.03.KINTOR PHARMA-B (09939): VOLUNTARY ANNOUNCEMENT - LONG-TERM SAFETY PHASE III CLINICAL TRIAL OF KX-826 FOR THE TREATMENT OF AGA REACHED PRIMARY ENDPOINT1
12.03.KINTOR PHARMA-B (09939): VOLUNTARY ANNOUNCEMENT - OPERATION COOPERATION AGREEMENT IN RELATION TO OVERSEAS MARKET OF COSMETICS2
11.03.KINTOR PHARMA-B (09939): DATE OF BOARD MEETING1
30.12.24KINTOR PHARMA-B (09939): VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST SUBJECT ENROLLMENT IN PHASE III STAGE PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE ...1
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1